05
051915.KO LG Chem Ltd
- Market cap
- KRW 8.56T
- P/E
- -
- P/B
- 0.23x
- ROE
- -1.3%
- Dividend yield
- 2.65%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 051915.KO undervalued?
Graham numberThe Graham number of LG Chem Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
LG Chem Ltd fundamental analysis
No fundamental analysis for LG Chem Ltd yet.
LG Chem Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About LG Chem Ltd
LG Chem, Ltd., together with its subsidiaries, operates as a chemical company in Korea, China, Asia/Oceania, the United States, Europe, and internationally. It offers ethylene-based synthetic resin products, such as ethylene vinyl acetate, high density polyethylene, low density polyethylene, linear low-density polyethylene, polyolefin elastomer, polyvinyl chloride, metallocene PE, and UNIQABLE, a recyclable all-PE packaging solution; and styrene-based synthetic resin, includ…
Full company profileLG Chem Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
LG Chem Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 20.7T | 25.7T | 28.2T | 28.6T | 30.1T | 42.7T | 51.9T | 55.2T | 48.7T | 45.9T | 52.8T |
| Gross Profit | 4.06T | 5.56T | 5.35T | 4.85T | 6.31T | 11.2T | 9.99T | 8.79T | 7.45T | 7.81T | 10.6T |
| Operating Income | 1.99T | 2.93T | 2.25T | 896B | 1.80T | 5.03T | 3.00T | 2.53T | 875B | 1.18T | 1.10T |
| EBITDA | - | 4.07T | 3.56T | 2.63T | 3.45T | 7.94T | 6.51T | 7.10T | 5.32T | 4.69T | 7.38T |
| Net Income | 1.28T | 1.95T | 1.47T | 313B | 513B | 3.67T | 1.85T | 1.34T | -691B | -1.82T | -470B |
| EPS | - | 28,217 | 21,361 | 4,545 | 7,310 | 52,262 | 26,278 | 18,951 | -9,787 | -25,774 | -6,651 |
| Balance Sheet | |||||||||||
| Total Assets | 20.5T | 25.0T | 28.9T | 34.0T | 41.4T | 51.1T | 68.0T | 34.1T | 93.9T | 101T | 112T |
| Total Liabilities | 6.44T | 8.70T | 11.6T | 16.6T | 22.6T | 27.9T | 30.5T | 13.7T | 45.9T | 54.0T | 63.3T |
| Shareholders' Equity | 13.9T | 16.2T | 17.1T | 17.0T | 18.0T | 21.7T | 31.5T | 20.4T | 33.3T | 32.8T | 35.4T |
| Cash & Short-term Investments | 1.47T | 2.25T | 2.51T | 1.89T | 3.27T | 3.76T | 8.50T | 2.10T | 7.85T | 9.90T | 11.1T |
| Cash Flow | |||||||||||
| Operating Cash Flow | 2.52T | 3.18T | 2.12T | 3.12T | 5.84T | 5.51T | 570B | 2.10T | 7.01T | 8.23T | 2.34T |
| Capital Expenditure | 1.47T | 2.25T | 4.22T | 6.24T | 5.54T | 5.77T | 8.41T | 2.42T | 14.8T | 13.9T | 8.65T |
| Free Cash Flow | - | 830B | -2.20T | -3.37T | 181B | -393B | -8.00T | -316B | -7.77T | -5.62T | -6.31T |
| Ratios | |||||||||||
| ROE | 9.2% | 12.0% | 8.6% | 1.8% | 2.8% | 16.9% | 5.9% | 6.6% | -2.1% | -5.5% | -1.3% |
| ROA | 6.3% | 7.8% | 5.1% | 0.9% | 1.2% | 7.2% | 2.7% | 3.9% | -0.7% | -1.8% | -0.4% |
| Net Profit Margin | 6.2% | 7.6% | 5.2% | 1.1% | 1.7% | 8.6% | 3.6% | 2.4% | -1.4% | -4.0% | -0.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
LG Chem Ltd dividends
- Dividend yield
- 2.65%
- Forward dividend
- 2,050.00 KRW
- Payout ratio
- -
- Ex-dividend date
- Mar 30, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 227B | 3,209 | - |
| 2024 | KRW 367B | 5,203 | - |
| 2023 | KRW 783B | 11,094 | 58.5% |
| 2022 | KRW 1.09T | 15,535 | 59.1% |
| 2021 | KRW 870B | 12,386 | 23.7% |
| 2020 | KRW 178B | 2,533 | 34.7% |
| 2019 | KRW 460B | 6,673 | 146.8% |
| 2018 | KRW 460B | 6,673 | 31.2% |
| 2017 | KRW 368B | 5,339 | 18.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 739:839 on Apr 20, 2009.
Who owns LG Chem Ltd
- Insiders 0.00%
- Institutions 19.72%
- Public & others 80.28%
- Shares outstanding 7.68M
- Free float 53.6M
LG Chem Ltd company profile
- Company name
- LG Chem Ltd
- Ticker
- 051915.KO
- ISIN
- KR7051911006
- Exchange
- Korea Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 12,063
- Fiscal year end
- December
- Address
- LG Twin Towers, Seoul, South Korea
- Phone
- 82 2 3773 1114
- Website
- lgchem.com
About LG Chem Ltd
LG Chem, Ltd., together with its subsidiaries, operates as a chemical company in Korea, China, Asia/Oceania, the United States, Europe, and internationally. It offers ethylene-based synthetic resin products, such as ethylene vinyl acetate, high density polyethylene, low density polyethylene, linear low-density polyethylene, polyolefin elastomer, polyvinyl chloride, metallocene PE, and UNIQABLE, a recyclable all-PE packaging solution; and styrene-based synthetic resin, including acrylonitrile butadiene styrene, acrylonitrile styrene acrylate, expandable polystyrene, polystyrene, styrene acrylonitrile copolymer. The company also provides polycarbonate, a benzene-based synthetic resin product; polypropylene, a propylene-based synthetic resin; superabsorbent polymer; butadiene rubber, nitrile butadiene rubber, nitrile butadiene rubber latex, styrene butadiene latex, and solution styrene butadiene rubber; caustic soda; plasticizer; and base oil. In addition, it offers bisphenol A; acrylate, alcohol, isopropyl alcohol, methacrylate butadiene styrene, neopentyl glycol, and styrene butadiene styrene; aerogel; anode binder and carbon nanotube; KEYFLEX BT, KEYFLEX TO, LUCEL, LUCON, LUMID/LUXY, LUMILOY, LUMIPLAS, LUPOL, LUPOS, LUPOX/LUMAX, LUPOY, and LUSEP high-performance plastics; display materials; adhesives for automotive bodyshop and cathode material paintshop, cathode material, dispersant for conductive agent, flame barrier material, and separators. Further, the company provides semiconductor materials and automobiles materials; life science products for arthritis, diabetes, growth hormone, fertility, anemia, anti-adhesive agent, antimicrobials, bovine somatotropin, vaccines, and crop protection agents. LG Chem, Ltd. was founded in 1947 and is headquartered in Seoul, South Korea.
LG Chem Ltd management
9- Mr. Dong-Choon KimPresident, CEO & Director · born 1968
- Mr. Dong Seok ChaExecutive VP, Internal Accounting Manager, CFO & Director
- Mr. Ji-yung YuCTO & Chief Sustainability Officer · born 1962
- Hyun-suk YoonHead of Investor Relations Division
- Seung-se ChangSenior Vice President
- Ms. Su-hee YoonSenior Vice President
- Mr. Cheol-Ho YangVP & Head of Petrochemical Management Strategy Group
- Dal-Mi HwangHead of Management Strategy - Life Sciences
- Mr. Young-Suk LeeVice President